Last updated 2026-07-26
- Raised $1.6M Series A, Jan 2025
- Raised $750k Seed round led by MEDX Xelerator, Feb 2019
Total raised
$2.4M
Last: Undisclosed Round 2025-02
Stage
Seed
Founded
2019
Headcount
30
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences
About
PatenSee is a clinical-stage medical device company developing a non-contact monitoring system for the early detection of vascular access stenosis in hemodialysis patients. Using advanced, multi-modal imaging technologies, AI, and machine learning, PatenSee's device alerts caregivers of vascular access stenosis risk at the earliest stage, enabling timely interventions to protect the patient's hemodialysis lifeline, improve the quality of care, and prolong the life of the fistula. PatenSee was founded at the MEDX Xelerator (an Israeli MedTech venture studio supported by the Israeli Innovation Authority) and operates out of Or Yehuda, Israel, and Detroit, Michigan.
Funding history · 2 rounds · $2.4M total
2025-01
A Round
$1.6M
2019-02
Seed
$750K
★ MEDX Xelerator★ MEDX Ventures Group★ Intellectual Ventures★ Israel Innovation Authority
Headcount over time
From 4 (2020-06) to 10 (2026-07) · +6 (+150%) · 17 points · source: Finder history + radar grounding
Q&A
- What is PatenSee's primary focus?
- PatenSee is a clinical-stage medical device company developing a non-contact monitoring system for the early detection of vascular access stenosis in hemodialysis patients.
- When was PatenSee founded and where is its headquarters?
- PatenSee was founded in 2019 and is headquartered in Or Yehuda, Israel.
- What was PatenSee's most recent funding round?
- In February 2025, PatenSee closed a Seed round, raising $2,000,000. Investors included Michigan Rise and Spark Capital.
- What is the total amount of funding PatenSee has raised to date?
- PatenSee has raised a total of $2,800,000 across its funding rounds.
- Has PatenSee received any significant regulatory designations recently?
- In September 2025, PatenSee received FDA Breakthrough Device Designation for its non-contact vascular access management system for hemodialysis patients.
- Did PatenSee enter into any clinical collaboration agreements recently?
- In February 2024, PatenSee and Fresenius Medical Care signed a clinical collaboration agreement.
- What technologies does PatenSee utilize in its product?
- PatenSee utilizes advanced multi-modal imaging technologies, AI, and machine learning in its device.
Team · 2
Hagay Drori
Founder · Co-founder
Oz Seadia
Founder · Co-founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital Healthcare
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftwareSimulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
early-detectionmedical-technologiesvascularremote-monitoringimagingdigital-healthcaredialysismedical-devicesmachine-learningartificial-intelligencehospitalsnon-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | patensee.com |
|---|---|
| linkedin.com/company/54099781 |
Identifiers & details
| Founded | 2019 |
|---|---|
| Employees (exact) | 30 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Web history (Wayback)
| Domain | patensee.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516013224 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-04-15 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — people (3), shares_capital (1) |
| Registered address | שרון אריאל 8 אור יהודה |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-31 | עדכון דירקטורים-הוספת דירקטור |
| 2025-12-31 | העברת מניות |
| 2025-12-25 | עדכון דירקטורים-הסרת דירקטור |
| 2025-11-02 | עדכון בעלי תפקידים |